QuVa Pharma Fentanyl Citrate Injection Recall: Lack of Sterility Assurance
QuVa Pharma recalls specific fentanyl injections due to lack of sterility assurance. Affected lots expire April 2025. Consumers should not use these products.
Stop using this now
Lack of Assurance of Sterility
Contact the company
What happened, in plain English
QuVa Pharma is recalling certain fentanyl injections that may not be sterile. This could lead to infections if used improperly. The recall affects specific lots with expiration dates up to April 2025. Read more at govinfonow.com/recall/32240-quva-pharma-fentanyl-citrate-injection-recall-lack-of-sterility-assurance.
Source Summary by GovInfoNow · govinfonow.com/recall/32240-quva-pharma-fentanyl-citrate-injection-recall-lack-of-sterility-assurance · Updated August 17, 2026 · FDA enforcement record: FDA #D-0296-2025
Cite this page
“QuVa Pharma Fentanyl Citrate Injection Recall: Lack of Sterility Assurance.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32240-quva-pharma-fentanyl-citrate-injection-recall-lack-of-sterility-assurance. Based on FDA recall #D-0296-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0296-2025%22&limit=1).
Why it’s dangerous
The injections lack assurance of sterility, meaning they could contain harmful bacteria or other contaminants. If used, this could cause serious infections or other health complications.
Who’s affected
Healthcare professionals using these injections for epidural procedures are affected. Patients receiving these injections at medical facilities using the recalled lots are at risk.
How to tell if you have this one
Check the product label for the specific lot numbers: 10140284, 10140285, 10140315, 10140316, 10140510, 10140916. The expiration dates range from April 2025 to April 2025.
- Brand
QuVa Pharma- Category
Drug
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
U.S. Nationwide
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0295-2025 | fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine HCl 100 mg/100 mL (1 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1255-75; Lots: 10140259, 10140539, 10140687, 10140688; Exp 04/24/2025 | N/A |
| D-0296-2025 | fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125 mg/100 mL (1.25 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1255-75; Lot, expiry: Lots 10140284, 10140285, 10140315, 10140316, exp 04/08/2025; Lot 10140510, exp 04/14/2025; Lot 10140916, exp 04/24/2025 | 2,310 cassettes |
| D-0297-2025 | fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.2% ROPivacaine HCl 200 mg/100 mL (2 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1259-75; Lot, expiry: Lot 10140303, exp 04/14/2025; Lots 10140867, 10140868, exp 04/24/2025; Lot 10140965, exp 04/28/2025 | 1,765 cassettes |
What to do — step by step
Stop Using Now
Immediately stop using the recalled fentanyl injections if you have them.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 27 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Questions people ask
What is the specific product being recalled?
The recalled product is fentanyl citrate injection (200 mcg/100 mL) with 0.125% bupivacaine, compounded for epidural use.
Similar recalls
Other QuVa Pharma recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0296-2025 (March 6, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0296-2025 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.